- Approaches to managing early loss of CAR T persistence in ALL – Sara Ghorashian,
- CAR T-cell therapy for AML- state of the art – Tobias Feuchtinger,
- Variables impacting outcome of CAR T-cell therapy for paediatric ALL – Liora Schultz.
You may register – free of charge – on the
EBMT homepage.Dear all,
it is our great pleasure to announce two exciting events from the PDWP in the field of CAR T cells therapy:
First, we will host an e-learning webinar on June 19th, 16:00-17:30 CEST, entitled “Update on CAR T-cell therapy on paediatric leukemia”, which provides an update of the state-of-the-art for CAR T-cell therapy for paediatric leukaemia and addresses the key issues in this field. This webinar is suitable for both paediatric and adult physicians/trainees with an interest in CAR T-cell therapy.
Moderators will be Persis Amrolia, Matthias Eyrich and Jochen Büchner, discussing with the speakers:
- Approaches to managing early loss of CAR T persistence in ALL – Sara Ghorashian,
- CAR T-cell therapy for AML- state of the art – Tobias Feuchtinger,
- Variables impacting outcome of CAR T-cell therapy for paediatric ALL – Liora Schultz.
You may register – free of charge – on the
EBMT homepage.
